Trabectedin in Advanced High-Grade Uterine Leiomyosarcoma: A Case Report Illustrating the Value of (18)FDG-PET-CT in Assessing Treatment Response

We report the case of a 60-year-old woman with metastatic high-grade uterine leiomyosarcoma who achieved a delayed response to second-line therapy with the marine-derived drug trabectedin (Yondelis(®), PharmaMar). We used 2-deoxy-2-[(18)F] fluorodeoxyglucose (FDG)-positron emission tomography (PET-C...

Descripción completa

Detalles Bibliográficos
Autores principales: Payne, M.J., Macpherson, R.E., Bradley, K.M., Hassan, A.B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2014
Materias:
Published online: February, 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975749/
https://www.ncbi.nlm.nih.gov/pubmed/24707261
http://dx.doi.org/10.1159/000355224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975749/
https://www.ncbi.nlm.nih.gov/pubmed/24707261
http://dx.doi.org/10.1159/000355224

Ejemplares similares